Canna Law Blog

FEBRUARY 25, 2022

If you keep a pulse on this issue, you know that for the past three years, the FDA has held the position that CBD cannot be marketed as a dietary ingredient because it was first studied and approved as a drug ingredient in GW Pharmaceuticals’ Epidiolex ( Drug Exclusion Rule ). According to NPA’s petition, the U.S.

CBD 80

CBD Safety Data Food 80

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. ” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

The Cannigma

FEBRUARY 1, 2023

Even if a cannabinoid has shown promise on one cancer line, that doesn’t mean it will work for all cancers – even if it’s within the same organ system. Advocate for the rescheduling of cannabis to improve access to cannabis for research purposes, and scientific funding for novel cannabinoid-based cancer therapies.

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

Cannabis Law Report

SEPTEMBER 24, 2019

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products? There are many different medical cannabis products. .

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. Forward-looking statements.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

OCTOBER 29, 2019

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

SEPTEMBER 7, 2021

A novel cannabinoid entered the public cannabis market for the first time anywhere recently, landing in Colorado. Despite these considerations, HHC vape carts hit the market without an accredited Certificate of Analysis (COA) or toxicity data. Overall, there are well over a dozen different forms of this unusual cannabinoid.

THC 93

THC Cannabinoids Digestion Data 93

Veriheal

OCTOBER 29, 2020

Is the focus on the negative impact due to the fact that role players want cannabis to remain illicit as to avoid its potential role in replacing pharmaceutical medication? The data for this graphic was provided by Jim Hudson at Hellth.com. . Scenario 2: Pharmaceuticals. However, the focus of funding remains on negative impacts.

Pharmaceutical 98

Pharmaceutical Therapy Cannabinoids Chronic Pain 98

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Consumers spent roughly $31.3 increase in annual sales. 2 The seeds of C.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JUNE 7, 2021

The Data and Safety Monitoring Committee (“DSMC”) for IGC’s clinical trial, having reviewed the data obtained through Cohort 1 and Cohort 2, recommended progressing to Cohort 3, which consists of administering three doses per day. This Phase 1 trial is currently testing IGC-AD1 for safety.

Clinical Trials 105

Clinical Trials Patients THC Safety 105

Cannabis Law Report

JUNE 7, 2019

The use of pharmaceutical cannabinoid products in Singapore comes under strict frameworks and regulations and does not diminish the country’s zero-tolerance position against drugs, the Home Affairs and Health ministries have said. Cannabinoids are chemical compounds found in the cannabis plant. The Straits Times Reports.

Pharmaceutical 40

Pharmaceutical Cannabinoids Safety Data 40

Canna Law Blog

FEBRUARY 21, 2020

Specifically, the FSA is giving the CBD industry until March 31, 2021 to submit valid novel food authorization applications to ensure these products meet specific safety standards. The EFSA guidance on cannabinoids strongly echoes the U.S. The EFSA guidance on cannabinoids strongly echoes the U.S.

Food 94

Food CBD Legalization Hemp 94

The Cannigma

FEBRUARY 16, 2021

They require a process in which THC or other cannabinoid particles are reduced to nanoscopic size that allows them to then be mixed with water or other aqueous liquids. There is not extensive safety data available, however. The nanoemulsion method ALT uses is effective for all cannabinoids, not only THC, he said.

Edibles 137

Edibles Digestion Tincture Cannabinoids 137

Cannabis Law Report

OCTOBER 6, 2021

Flora Pharma will seek to identify scientific gaps in the cannabis industry and ultimately work to translate that to pharmaceutical cannabis products backed by data. Flora Pharma expects to fast track traditional FDA and NHS timelines by running phase trials in parallel (in vitro, in vivo, pilot in human, safety/efficacy, etc.).

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Events 52

The Cannigma

AUGUST 22, 2021

Cannabis tampons are tampons that have been infused with cannabinoids such as CBD or THC. The idea is that the tampon is inserted vaginally as a way to apply cannabinoids to treat vaginal and abdominal pain caused by menstruation, endometriosis, and other gynecological conditions. Are CBD tampons safe?

THC 119

THC CBD Research and Development Conditions 119

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.

Research and Development 108

Research and Development Data THC Clinical Trials 108

The Cannigma

JUNE 15, 2021

Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. The two cannabinoids can also cause very different effects in other ways. CBD is also often compared to CBG (cannabigerol) , another increasingly popular cannabinoid. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

FEBRUARY 15, 2019

The Singapore Online Citizen reports… Law & Home Affairs Minister K Shanmugam says that pharmaceutical companies are hiding their intentions behind a smokescreen when it comes to cannabis. On the other hand, they found that are some medicine with cannabinoid products that are scientifically researched and medically approved.

Medicine 45

Medicine Pharmaceutical Law Cannabinoids 45

Cannabis Law Report

JANUARY 24, 2022

Company is on track to announce interim data in mid-2022 from its Phase 2 clinical trial for lead kidney precision medicine product candidate GFB-887. In 2022, we anticipate reading out interim data from our ongoing Phase 2 clinical trial of GFB-887, as well as initial data from our ongoing Phase 1 study of GFB-024.

Clinical Trials 52

Clinical Trials Research and Development Data Medicine 52

Cannabis Law Report

SEPTEMBER 20, 2021

The products leverage pharmaceutical technology to maximize performance and safety. CB4 products are formulated based on the latest medical evidence and come in convenient dosage forms that deliver effective levels of cannabinoids. Opticann medical cannabis products merge cannabis medicine with modern medicine.

Clinical Trials 52

Clinical Trials Pharmaceutical Data Patients 52

Cannabis Law Report

NOVEMBER 22, 2019

“As MMJ International Holdings continues to advance to its clinical trials, a specialty pharmaceutical solutions company will be supporting MMJ with the FDA, DEA required development API and specialized liquid encapsulation solutions,” said Elio Mariani, PhD, EVP of Research & Development. Orphan Drug Designation?

DEA 66

DEA Clinical Trials THC Research and Development 66

Cannabis Law Report

NOVEMBER 24, 2019

Building the bridge between brands and the marketplace through testing and the importance of good data. These events, amongst other drivers, have shown the obvious need to regulate product safety in CBD and THC products in a holistic and standardized way.

Business 95

Business Data Wellness and Beauty Safety 95

Puff Puff Post

NOVEMBER 5, 2019

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. VANCOUVER, Nov. About INM-755.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

Cannabis Law Report

JUNE 9, 2022

11:00-12:00 PM: Interstate Commerce: Impacts on markets, licensing, and consumer safety. 3:15-4:15 PM: Preventing Youth Access, Promoting Consumer Safety, & Protecting Public Health in State Markets. Panelists: Darrin Grondel, EdD, Vice President of Traffic Safety & Government Relations, Responsibility.org.

Policy 52

Policy Safety Seed-To-Sale Data 52

NORML

AUGUST 26, 2019

There are currently five “pharmaceutical processor” permit holders in Virginia, and they’re about to open for business. ” and “We only want to see data from an American source.” There are some minimum and maximum cannabinoid contents with the program.

Marijuana 205

Marijuana Legalization Programs Oil 205

Cannabis Law Report

DECEMBER 7, 2021

Despite the massive and growing market size, there is still scant data on the effectiveness of over-the-counter cannabinoid products due to the cost, speed and scale limitations of the current approach to scientific research,” said Jeff Chen, MD/MBA, Co-founder and CEO of Radicle Science. in less than four days. About Radicle Science.

Clinical Trials 52

Clinical Trials CBD Data Sleep 52

CannaMD

MAY 14, 2020

Data from Colorado, which was among the first states to legalize marijuana, indicates that edible cannabis-infused products account for some 45% of all cannabis sales. These figures do not include homemade edibles made from cannabinoid-infused oils, so the actual percentage of use may be higher!). Safety of production and packaging.

Edibles 105

Edibles Marijuana THC Vaping 105

Otherside Farms

JANUARY 22, 2019

While federal regulations help ensure the consistency and quality of our food and pharmaceuticals, marijuana’s continued status as a Schedule 1 illegal substance keeps it from the protection and oversight offered to other consumer products. But that will take time, and leaves the individual with very limited data about their cannabis.

Terpenes 40

Terpenes Strains Data Cannabinoids 40

Cannabis Law Report

AUGUST 23, 2021

Abernethy said, “We [FDA] remain focused on exploring potential pathways for CBD products to be lawfully marketed while also educating the public about these outstanding questions of CBD’s safety.”. He added that significant data is still needed to inform policy regarding use of consumer cannabis products.

Pets 105

Pets Hemp CBD Food 105

Healer

APRIL 5, 2021

However, if you have not experienced the power of CBDA (and most people haven’t because CBDA is not included in most products that are manufactured with heat), this guide will explain what we are now learning about this powerful minor cannabinoid and how it can work together with CBD or in place of CBD to address and prevent symptoms.

CBD 98

CBD Chronic Pain Oil Topical 98

Cannabis Law Report

FEBRUARY 2, 2022

Cannabis represents a potential cornucopia of medicinal and pharmaceutical advancement. Cannabis produces over 550 different phytochemicals, over 120 of which are cannabinoids like THC and CBD. Other cannabinoids like Varins (CBGV, THCV, and CBDV) are less well known and potentially offer significant value. BILLERICA, Mass.,

Extraction 52

Extraction Pharmaceutical Hemp Cultivation 52

Cannabis Law Report

JANUARY 11, 2019

CBD was flying off the shelves in Austria, as elsewhere in Europe, until the government stepped in recently to effectively outlaw the handling of certain cannabinoid products. it illegal to grow cannabis with the intent to produce the psychoactive cannabinoid THC, Austrians can purchase cannabis seeds and seedlings legally.

Seed-To-Sale 49

Seed-To-Sale Food Hemp Oil 49

Cannabis Law Report

DECEMBER 8, 2019

AJEM’s mission is to create, collect, and disseminate credible cannabis research data. Indeed, the discovery of the endocannabinoid system (ECS), and the fact that it can be modulated by exogenous phytocompounds called cannabinoids produced by the Cannabis sativa L. Thus, the source of a cannabinoid determines its legal status.

Medicine 59

Medicine Research and Development Food Cannabinoids 59

Veriheal

AUGUST 31, 2020

Essay Summary: Although doctors’ offices are full of pamphlets and flyers about mainstream pharmaceuticals in both English and Spanish, there is a lack of information for Hispanic patients seeking relief with cannabis and CBD. . Essay: “Crowdsourcing User Experience Data for a Targeted Medical Cannabis Journey with Cannamunity” .

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. Data collection. 2016 ; Sznitman et al.

Research and Development 52

Research and Development Medicine Access Media 52

Puff Puff Post

DECEMBER 28, 2018

An official study is aimed to conclude in July of 2019, where we’ll see all the data which comes forth. Influencing how information is processed and how nerve cells and synapses in the brain interact, the exact function related to autism is still not well understood, and no pharmaceuticals around yet can ‘fix’ autism.

Treatment 76

Treatment Oil CBD Therapy 76

Healer

APRIL 5, 2021

However, if you have not experienced the power of CBDA (and most people haven’t because CBDA is not included in most products that are manufactured with heat), this guide will explain what we are now learning about this powerful minor cannabinoid and how it can work together with CBD or in place of CBD to address and prevent symptoms.

CBD 52

CBD Chronic Pain Oil Topical 52